Michèle Reboud-Ravaux - Search Results

Year	Number of Results
2002	4
2003	2
2004	2
2006	3
2007	4
2008	4
2009	4
2010	4
2011	1
2012	3
2013	5
2014	5
2015	3
2017	2
2018	3
2020	1
2021	4
2024	0

1

Erratum : Dégradation induite des protéines par des molécules PROTAC et stratégies apparentées : développements à visée thérapeutique - Biologie Aujourd’hui 215 (1-2), 25-43 (2021) https://doi.org/10.1051/jbio/2021007.

Reboud-Ravaux M. Reboud-Ravaux M. Biol Aujourdhui. 2021;215(3-4):143. doi: 10.1051/jbio/2022001. Epub 2022 Mar 11. Biol Aujourdhui. 2021. PMID: 35275059 French. No abstract available.

2

Cryptic activities of fibronectin fragments, particularly cryptic proteases.

Pagano M, Reboud-Ravaux M. Pagano M, et al. Among authors: reboud ravaux m. Front Biosci (Landmark Ed). 2011 Jan 1;16(2):698-706. doi: 10.2741/3713. Front Biosci (Landmark Ed). 2011. PMID: 21196196 Free article. Review.

3

Dimerization inhibitors of HIV-1 protease.

Boggetto N, Reboud-Ravaux M. Boggetto N, et al. Among authors: reboud ravaux m. Biol Chem. 2002 Sep;383(9):1321-4. doi: 10.1515/BC.2002.150. Biol Chem. 2002. PMID: 12437124 Review.

4

Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors.

Bayot A, Basse N, Lee I, Gareil M, Pirotte B, Bulteau AL, Friguet B, Reboud-Ravaux M. Bayot A, et al. Among authors: reboud ravaux m. Biochimie. 2008 Feb;90(2):260-9. doi: 10.1016/j.biochi.2007.10.010. Epub 2007 Oct 25. Biochimie. 2008. PMID: 18021745 Review.

5

Linear TMC-95-based proteasome inhibitors.

Basse N, Piguel S, Papapostolou D, Ferrier-Berthelot A, Richy N, Pagano M, Sarthou P, Sobczak-Thépot J, Reboud-Ravaux M, Vidal J. Basse N, et al. Among authors: reboud ravaux m. J Med Chem. 2007 Jun 14;50(12):2842-50. doi: 10.1021/jm0701324. Epub 2007 May 19. J Med Chem. 2007. PMID: 17511440

6

Proteasome inhibitors.

Reboud-Ravaux M. Reboud-Ravaux M. Prog Mol Subcell Biol. 2002;29:110-25. Prog Mol Subcell Biol. 2002. PMID: 11908069 Review. No abstract available.

7

Structure-based design of human immuno- and constitutive proteasomes inhibitors.

Richy N, Sarraf D, Maréchal X, Janmamode N, Le Guével R, Genin E, Reboud-Ravaux M, Vidal J. Richy N, et al. Among authors: reboud ravaux m. Eur J Med Chem. 2018 Feb 10;145:570-587. doi: 10.1016/j.ejmech.2018.01.013. Epub 2018 Jan 8. Eur J Med Chem. 2018. PMID: 29339252 Free article.

8

Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.

Bosc E, Nastri J, Lefort V, Valli M, Contiguiba F, Pioli R, Furlan M, Bolzani VDS, El Amri C, Reboud-Ravaux M. Bosc E, et al. Among authors: reboud ravaux m. Biochem Biophys Res Commun. 2018 Feb 12;496(3):961-966. doi: 10.1016/j.bbrc.2018.01.100. Epub 2018 Feb 2. Biochem Biophys Res Commun. 2018. PMID: 29355526

9

[Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].

Reboud-Ravaux M. Reboud-Ravaux M. Biol Aujourdhui. 2021;215(1-2):25-43. doi: 10.1051/jbio/2021007. Epub 2021 Aug 16. Biol Aujourdhui. 2021. PMID: 34397373 French.

10

Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism.

Soualmia F, Bosc E, Amiri SA, Stratmann D, Magdolen V, Darmoul D, Reboud-Ravaux M, El Amri C. Soualmia F, et al. Among authors: reboud ravaux m. Biol Chem. 2018 Sep 25;399(9):1073-1078. doi: 10.1515/hsz-2017-0336. Biol Chem. 2018. PMID: 29641412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year